Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Koff

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|May 2, 1974
Pathogenesis of experimental viral hepatitis (second of two parts)S M Sabesin, R S Koff
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1976
Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximideR S Koff, L J Connelly
Hepatology (Baltimore, Md.)|October 21, 2000
Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis CR J Jacobs, R S Koff
Biochemical Pharmacology|April 1, 1972
Increased plasma enzyme activity induced by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A)R S Koff, J J Fitts
Biochemical Medicine|February 1, 1972
Chlorpromazine inhibition of ethanol metabolism without prevention of fatty liverR S Koff, J J Fitts
Seminars in Liver Disease|February 1, 1995
Extrahepatic manifestations of hepatitis C and the association with alcoholic liver diseaseR S Koff, J L Dienstag
Gastroenterology|May 1, 1984
Passive and active immunoprophylaxis of hepatitis BL B Seeff, R S Koff
Seminars in Liver Disease|February 1, 1986
Evolving concepts of the clinical and serologic consequences of hepatitis B virus infectionL B Seeff, R S Koff
Experimental and Molecular Pathology|June 1, 1976
D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liverS M Sabesin, R S Koff
American Journal of Public Health|February 1, 1976
Failure to detect hepatitis B surface antigen (HBsAg) in certified shellfish from New EnglandR S Koff, L J Connelly
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|May 2, 1974
Pathogenesis of experimental viral hepatitis (second of two parts)S M Sabesin, R S Koff
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1976
Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximideR S Koff, L J Connelly
Hepatology (Baltimore, Md.)|October 21, 2000
Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis CR J Jacobs, R S Koff
Biochemical Pharmacology|April 1, 1972
Increased plasma enzyme activity induced by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A)R S Koff, J J Fitts
Biochemical Medicine|February 1, 1972
Chlorpromazine inhibition of ethanol metabolism without prevention of fatty liverR S Koff, J J Fitts
Seminars in Liver Disease|February 1, 1995
Extrahepatic manifestations of hepatitis C and the association with alcoholic liver diseaseR S Koff, J L Dienstag
Gastroenterology|May 1, 1984
Passive and active immunoprophylaxis of hepatitis BL B Seeff, R S Koff
Seminars in Liver Disease|February 1, 1986
Evolving concepts of the clinical and serologic consequences of hepatitis B virus infectionL B Seeff, R S Koff
Experimental and Molecular Pathology|June 1, 1976
D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liverS M Sabesin, R S Koff
American Journal of Public Health|February 1, 1976
Failure to detect hepatitis B surface antigen (HBsAg) in certified shellfish from New EnglandR S Koff, L J Connelly
Pageof 18